CRISPR is one of this generation’s most profound innovations, with the potential to fundamentally alter the realm of modern day diagnostics and medical treatment. Scientists can use the tool to make ...
Gene-editing techniques such as CRISPR-Cas9 have many uses in the area of food and agriculture. They can combat persistent drought and disease, and improve the colour and nutritional content of food ...
In a decision announced today (March 26), the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (USPTO and PTAB, respectively) reaffirmed its original decision that the Broad Institute, ...
CRISPR-Cas 9 is a gene-editing tool that made it possible to rewrite any organism's genetic code and tackle genetic diseases more effectively. Known as genetic scissors, CRISPR identifies a DNA ...
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on ...
Scientists have discovered a powerful gene-targeting system in viruses. Billions of years old, VIPR seems to predate CRISPR and may be even more powerful.
The pioneers of the CRISPR gene-editing tool won a Nobel prize in 2020, and for good reason. The breakthrough has revolutionised biology, and is also transforming medicine and farming. Now, AI company ...
A new engineered gene-editing system, proven in bacteria and showing promise for use in plants, animals and humans, addresses ...
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using CRISPR-Cas9 in combination with AAV6 vectors can trigger inflammatory and ...
CRISPR Therapeutics AG remains a long-term Buy, anchored by Casgevy's success and management’s execution in ex vivo gene editing. Click for more on CRSP.